Hyperice, Inc.

I'll verify the underlying facts before drafting, since the structured record here identifies a corporate party rather than a law firm.

Let me verify the enforcement campaign, ITC ruling, and PTAB history.

Note on the record before drafting: the structured profile supplied for this analysis identifies the entity as Hyperice, Inc., with "attorneys" Brian Arnold and Jon Howell and a single tracked appearance. Hyperice is not a law firm — it is an Irvine, California-based recovery-technology manufacturer, and the trackers have captured its in-house legal function as the "firm." The summary below therefore describes Hyperice's patent enforcement program and the outside counsel who staff it, rather than a law-firm practice. No AmLaw, Chambers, Vault, or AmLaw revenue/headcount ranking applies, because none of those rank corporate legal departments.

Entity overview and size. Hyperice, Inc. is a privately held health-and-recovery company founded in 2010 (some sources say 2011), headquartered at 525 Technology Drive, Irvine, CA, with founder Anthony Katz and CEO Jim Huether. Third-party data aggregators list roughly 200 employees; the Orange County Business Journal reported an $850 million valuation in 2024 following a $700 million valuation in 2020. Its legal function is small — then-General Counsel Jon Howell told the OCBJ its in-house team had grown to three people. This is a sophisticated mid-market consumer-products company with a lean in-house department that runs its patent program through outside litigation counsel; it is neither BigLaw, an IP boutique, nor a regional patent shop.

Technology areas. Hyperice's patent activity is concentrated in electromechanical consumer-recovery devices, not software, pharma, or semiconductors. The asserted patents in the public record are: U.S. 10,561,574 ("percussive massage" utility patent), design patents D855,822 and D886,317, and U.S. 11,857,482 ("Massage Device Having Variable Stroke Length," issued Jan. 2, 2024, claiming priority to 2013–2014), which covers the Hypervolt line's piston/Scotch-yoke drive and magnetic quick-connect massage-head system. The portfolio spans percussion (Hypervolt), vibration (Vyper, Hypersphere), dynamic air compression (Normatec), thermal (Venom), and contrast therapy (Hyperice X). A 2020 suit against Therabody (Theragun) asserted patented vibrating-roller technology.

Side preference — plaintiff only. Hyperice is a pure patent plaintiff and brand enforcer, consistent with the tracked record (1 plaintiff-side appearance, 0 defendant-side). It asserts its own operating-company patents against competitors and, more often, against importers of knockoff massage guns. There is no evidence of NPE/PAE-style assertion, no assertion of third-party-acquired patents for licensing revenue, and no defense-side patent role identified. Public reporting describes an explicit strategy of "aggressively defend[ing] our intellectual property rights," and its enforcement has included both district-court actions and Section 337 proceedings. The tracked dataset (one case) is materially under-inclusive of the actual campaign, which has involved dozens of named respondents.

Notable matters and outcomes. (1) In re Certain Percussive Massage Devices, Inv. No. 337‑TA‑1206 (ITC) — Hyperice filed June 17, 2020 against 19 respondents; after settlements with 11 respondents and defaults by five, the Commission issued a general exclusion order on December 16, 2021 covering claims 1–7, 9, 14, and 15 of the '574 patent, plus cease-and-desist orders against defaulting respondents, with a 100% bond during Presidential Review (86 FR 72624). The GEO excluded infringing devices regardless of whether the importer was a named respondent. Notably, the Commission terminated the two asserted design patents for lack of standing after Staff (OUII) successfully argued that a co-inventor had not assigned his rights before institution — a significant adverse ruling in an otherwise favorable outcome. (2) Hyper Ice, Inc. v. Joicom Corp. d/b/a Renpho, No. 8:24‑cv‑00098 (C.D. Cal., Judge John W. Holcomb) — the tracked case; filed January 16, 2024 on the '482 patent against Renpho's percussive massage-gun line; Renpho denied infringement, counterclaimed for invalidity, and asserted willfulness and $10–30 million in estimated damages in the parties' Rule 26(f) report. The case was consolidated for pretrial purposes through the Markman hearing with several related Hyperice actions (8:24‑cv‑00099, ‑00390, ‑00391, and 2:24‑cv‑03212), stayed in its entirety on August 9, 2024 pending resolution of Hyper Ice, Inc. v. MerchSource, LLC, No. 8:24‑cv‑00410, and administratively closed; a stipulation of dismissal was filed in July 2024. I could not verify a final merits outcome, verdict, or settlement amount for this or the related 2024 actions, and no 2025–2026 docket update was confirmed. (3) Hyperice v. Therabody (2020, vibrating-roller patent) — outcome not verified in the sources reviewed. (4) Hyperice v. MerchSource/Sharper Image — the 2021 infringement action that the PTAB ruling below was intended to unblock.

PTAB / IPR posture. Hyperice's public IPR posture is defensive, not offensive: it has not been identified as a frequent petitioner. It prevailed in a PTAB proceeding in which Sharper Image/MerchSource sought review of a Hyperice massage-gun patent; on August 5, 2022, the Board denied institution, finding the petitioner failed to show a reasonable likelihood of prevailing on any challenged claim. Hyperice's counsel described a deliberate strategy of statutorily disclaiming six of the patent's 18 claims — claims unasserted in the district court case — to keep the challenged set narrow and protect the commercially important claims. Hyperice also faced at least one IPR petition from an ITC respondent (per contemporaneous Chinese-language reporting on 337‑TA‑1206), but I could not verify its resolution. No public report supports a quantified IPR/PGR filing volume for Hyperice.

Key personnel. In-house: Jon Howell, General Counsel / Chief Legal Officer (joined Hyperice February 2020; previously Czech & Howell APC; OCBJ 2022 General Counsel Award, private-company category); Brian G. Arnold, Assistant/Associate General Counsel and Head of Intellectual Property (California Bar No. 186007, business address at Hyperice's Irvine HQ; previously partner at Lewis Brisbois, where he led the Hyperice ITC matter, and later at Lewis Roca; a 2025 ACC event listing confirms his Hyperice title). Outside counsel of record on the tracked Renpho case: Miller Barondess LLP (Ben Herbert) and Lewis Brisbois Bisgaard & Smith LLP (Mike Lyons for Renpho). Historical Hyperice patent counsel includes Jonathan Pink and Joshua D. Curry (Lewis Brisbois) on the ITC matter, and Kyle Kellar and Kurt Prange (Lewis Roca, subsequently Womble Bond Dickinson) on the PTAB win alongside Arnold. Hyperice does not itself maintain a partner roster; the "top attorneys" in the structured data are the company's in-house lawyers, not law-firm partners.